Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Homologous Recombination Repair
100%
Patient Selection
100%
DNA Repair
100%
Pancreatic Cancer
100%
Rucaparib
62%
PARP Inhibitors (PARPi)
50%
BRCA2
37%
Pancreatic Cancer Cells
37%
Cancer Patients
25%
Prognostic Biomarker
25%
DNA Double-strand Breaks
25%
Cancer Susceptibility Genes
25%
Pancreatic Tumor
25%
PARP Inhibitor Therapy
12%
In Vitro Cell Line Model
12%
Repair Mechanism
12%
Molecular Changes
12%
Resistance Mechanism
12%
BRCA2 mutation
12%
Somatic Alterations
12%
Phase II Trial
12%
PALB2
12%
Gene Sequencing
12%
Associated Genes
12%
Gene Alteration
12%
Homologous Recombination Deficiency
12%
Patient Materials
12%
Phase I Study
12%
DNA Instability
12%
BRCA mutation
12%
Gene Expression
12%
Therapeutic Decision-making
12%
DNA Gene
12%
In Cancer
12%
DNA Damage Response
12%
Treatment Refractory
12%
Breast Cancer
12%
Tumor
12%
Cell-based
12%
Response to Chemotherapy
12%
Pancreatic Adenocarcinoma
12%
DNA Repair Genes
12%
Response Predictors
12%
Biochemistry, Genetics and Molecular Biology
Homologous Recombination
100%
Recombination Repair
100%
DNA Repair
100%
Poly ADP Ribose Polymerase
55%
BRCA2
44%
Cancer Cell
33%
BRCA1
33%
Double-Strand DNA Break
22%
Susceptibility Gene
22%
Erethism
11%
Gene Sequence
11%
Repair Gene
11%
Prognostic Biomarker
11%
Preclinical Study
11%
Deficiency
11%
Mediator
11%
Phase II Trials
11%
DNA Damage Response
11%
Gene Expression
11%
PALB2
11%